Alopecia areata. Other alopecia areata
Conditions
Interventions
Intervention 1: Intervention group: taking Diphen Ciprone and platelet-rich plasma together. All patients participating in the study received diphen cyprone and PRP simultaneously on one side of their
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: A patient with alopecia areata whose definitive diagnosis was made on clinical or histological basis and their involvement was severe (> 50% scalp area and less than 100%). Positive response to test with 2% Diphen Ciprone solution
Exclusion criteria
Exclusion criteria: Patients with alopecia totalis or universalis Receive any systemic treatment during the last 6 months Children under 18 years Pregnant and lactating women Immunosuppressed patient patient with platelet dysfunction patient with a history of injecting steroids on the site over the past month Fever, systemic infection and local infection at the injection site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity alopecia tool score (SALT score). Timepoint: Trichoscopic evaluation at baseline, 3 months later, 6 months later. Method of measurement: Trichoscope. | — |
Secondary
| Measure | Time frame |
|---|---|
| SALT score evaluation. Timepoint: Evaluation at baseline, 3 months later, 6 months later. Method of measurement: visual evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Rezayat
Tehran University of Medical Sciences
Outcome results
None listed